Literature DB >> 10378785

The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.

N Iizuka1, A Tangoku, H Hayashi, S Yosino, T Abe, T Morioka, M Oka.   

Abstract

The nm23 gene is a potential metastasis suppressor gene originally identified using a murine melanoma cell line. The expression of nm23-H1 protein was examined immunohistochemically in 50 eligible patients with esophageal squamous cell carcinoma (ESCC). The expression was not correlated with other prognostic factors including lymph node metastases; however, overall survival rates of nm23-H1-negative patients were significantly shorter than those of nm23-H1-positive patients (P < 0.05). Furthermore, reduced expression of nm23-H1 was associated with shorter overall survival in patients with involved lymph nodes (P < 0.01), but not in patients without involved lymph nodes. These data support the conclusion that reduced expression of nm23-H1 may be associated with poor prognosis of ESCC patients, suggesting the value of nm23-H1 expression as a prognostic marker for ESCC patients, especially ESCC patients with involved lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378785     DOI: 10.1016/s0304-3835(98)00387-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Differences of onset age and survival rates in esophageal squamous cell carcinoma cases with and without family history of upper gastrointestinal cancer from a high-incidence area in North China.

Authors:  Denggui Wen; Shijie Wang; Liwei Zhang; Jianhui Zhang; Lizhen Wei; Xiuqing Zhao
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.

Authors:  S Kapitanović; T Cacev; M Berković; M Popović-Hadzija; S Radosević; S Seiwerth; S Spaventi; K Pavelić; R Spaventi
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 3.  Nm23/nucleoside diphosphate kinase in human cancers.

Authors:  M T Hartsough; P S Steeg
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 4.  Basic and translational advances in cancer metastasis: Nm23.

Authors:  Taoufik Ouatas; Massimiliano Salerno; Diane Palmieri; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

5.  Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma.

Authors:  Jian-Xiong Zhao; Xue-Feng Li; Xue-Xi Wang
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

6.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

Review 7.  Inhibition of signal transduction by the nm23 metastasis suppressor: possible mechanisms.

Authors:  Massimiliano Salerno; Taoufik Ouatas; Diane Palmieri; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Prognostic value of nm23 in gastrointestinal stromal tumors.

Authors:  Ozkan Kanat; Saduman Adim; Turkkan Evrensel; Omer Yerci; Bulent Ediz; Ender Kurt; Mutlu Demiray; Guzin Gonullu; Murat Arslan; Osman Manavoglu
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

9.  Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.

Authors:  Wan-li Liu; Xian-zhi Guo; Lan-jun Zhang; Jun-ye Wang; Ge Zhang; Su Guan; Yu-min Chen; Qing-li Kong; Li-hua Xu; Man-zhi Li; Li-bing Song; Mu-sheng Zeng
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

10.  Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.

Authors:  M Tomita; T Ayabe; Y Matsuzaki; M Edagawa; M Maeda; T Shimizu; M Hara; T Onitsuka
Journal:  BMC Cancer       Date:  2001-04-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.